J. Mark Sloan, MD

Associate Professor, Medicine

J. Sloan
617.638.7520
820 Harrison Ave

Biography

My clinical expertise is in clinical hematology, especially lymphoma, leukemia, myeloma, amyloidosis, myelodysplasia and bone marrow transplantation. I also have expertise in the treatment of Jehovah’s witnesses

Education

  • Yale University School of Medicine, MD
  • Harverford College, BS

Classes Taught

Publications

  • Published on 6/19/2018

    Nguyen VP, Landau H, Quillen K, Brauneis D, Shelton AC, Mendelson L, Rahman H, Sloan JM, Sarosiek S, Sanchorawala V. Modified high-dose melphalan and autologous stem cell transplantation for AL amyloidosis: Experience in 334 patients. Biol Blood Marrow Transplant. 2018 Jun 19. PMID: 29933072.

    Read at: PubMed
  • Published on 6/14/2018

    Sarosiek S, Quillen K, Sloan JM, Brauneis D, Sanchorawala V. Heparin-induced thrombocytopenia and thrombosis during high dose melphalan and autologous stem cell transplantation. Blood. 2018 Jun 14. PMID: 29903887.

    Read at: PubMed
  • Published on 6/8/2018

    White PS, Phull P, Brauneis D, Sloan JM, Quillen K, Sarosiek S, Sanchorawala V. High-dose melphalan and stem cell transplantation in AL amyloidosis with elevated cardiac biomarkers. Bone Marrow Transplant. 2018 Jun 08. PMID: 29884854.

    Read at: PubMed
  • Published on 4/26/2018

    Pudusseri A, Smith I, Sarnacki D, Brauneis D, Shelton A, Sanchorawala V, Sloan JM, Sarosiek S, Quillen K. Evaluation of a new continuous mononuclear cell collection procedure in a single transplant center cohort enriched for AL amyloidosis patients. Transfus Apher Sci. 2018 Apr 26. PMID: 29731423.

    Read at: PubMed
  • Published on 2/1/2018

    Dobry AS, Ko LN, St John J, Sloan JM, Nigwekar S, Kroshinsky D. Association Between Hypercoagulable Conditions and Calciphylaxis in Patients With Renal Disease: A Case-Control Study. JAMA Dermatol. 2018 Feb 01; 154(2):182-187. PMID: 29238798.

    Read at: PubMed
  • Published on 12/21/2017

    Nguyen VP, Brauneis D, Kaku M, Sloan JM, Sarosiek S, Quillen K, Shelton AC, Sanchorawala V. Neuralgic amyotrophy following high-dose melphalan and autologous peripheral blood stem cell transplantation for AL amyloidosis. Bone Marrow Transplant. 2018 Mar; 53(3):371-373. PMID: 29269794.

    Read at: PubMed
  • Published on 9/1/2017

    Batalini F, Econimo L, Quillen K, Sloan JM, Sarosiek S, Brauneis D, Havasi A, Stern L, Dember LM, Sanchorawala V. High-Dose Melphalan and Stem Cell Transplantation in Patients on Dialysis Due to Immunoglobulin Light-Chain Amyloidosis and Monoclonal Immunoglobulin Deposition Disease. Biol Blood Marrow Transplant. 2018 Jan; 24(1):127-132. PMID: 28865972.

    Read at: PubMed
  • Published on 7/24/2017

    Arun M, Brauneis D, Doros G, Shelton AC, Sloan JM, Quillen K, Ruberg FL, Sanchorawala V, Varga C. The incidence of atrial fibrillation among patients with AL amyloidosis undergoing high-dose melphalan and stem cell transplantation: experience at a single institution. Bone Marrow Transplant. 2017 09; 52(9):1349-1351. PMID: 28737773.

    Read at: PubMed
  • Published on 7/15/2017

    Gordon CE, Chitalia VC, Sloan JM, Salant DJ, Coleman DL, Quillen K, Ravid K, Francis JM. Thrombotic Microangiopathy: A Multidisciplinary TeamĀ Approach. Am J Kidney Dis. 2017 Nov; 70(5):715-721. PMID: 28720207.

    Read at: PubMed
  • Published on 7/11/2017

    Browning S, Quillen K, Sloan JM, Doros G, Sarosiek S, Sanchorawala V. Hematologic relapse in AL amyloidosis after high-dose melphalan and stem cell transplantation. Blood. 2017 09 14; 130(11):1383-1386. PMID: 28698204.

    Read at: PubMed

View 37 more publications: View full profile at BUMC

View all profiles